Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02099864
Title Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.